Editorials: Times, Journal disagree on interim FDA leader

09/27/2005 | NYTimes.com · Wall Street Journal, The

Editorials in The New York Times and The Wall Street Journal say the resignation of FDA commissioner Lester Crawford gives the Bush administration the opportunity to put effective leadership in place at the agency, but the papers disagree on who should be the new leader. The Times said the interim choice, Dr. Andrew von Eschenbach, has received "mixed reviews" during his time at the National Cancer Institute, while the Journal said he understands the need to "speed good therapies to patients."

View Full Article in:

NYTimes.com · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN